PhreesiaPHR +10.30%65 Days Payable is 24.60 as of Apr. 2026, which is 9% below its 10-year median of 27.01. GuruFocus rates PHR with a GF Score™ of 65/100 and a GF Value™ of $26.97 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Phreesia ranks worse than 85.31% on this metric.
Phreesia's average Accounts Payable for the
three
months ended in Apr. 2026 was $11.7 Mil. Phreesia's Cost of Goods Sold for the
three
months ended in Apr. 2026 was $43.3 Mil.
Hence, Phreesia's Days Payable for the
three
months ended in Apr. 2026 was 24.60.
The historical rank and industry rank for Phreesia's Days Payable or its related term are showing as below:
PHR'
s Days Payable Range Over the Past 10 Years
Min: 18.01 Med: 27.01 Max: 39.86
Current: 18.01
During the past 9 years, Phreesia's highest Days Payable was 39.86. The lowest was 18.01. And the median was 27.01.
PHR's Days Payable is ranked worse than 85.31% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs PHR: 18.01
Phreesia's Days Payable
increased
from Apr. 2025 (10.58) to Apr. 2026 (24.60).
It may suggest that Phreesiadelayed paying its suppliers.
Phreesia Days Payable Related Terms
Phreesia Days Payable Historical Data
* Premium members only.
The historical data trend for Phreesia's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Phreesia's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phreesia Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's Days Payable distribution charts can be found below:
* The bar in red indicates where Phreesia's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Phreesia's Days Payable for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phreesia (PHR) has a Days Payable of 24.60 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Phreesia and its competitors. This is near median its historical median of 27.01. Over the past decade, Phreesia's Days Payable has ranged from 18.01 to 39.86. According to the industry distribution chart, Phreesia ranks #517 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 85.3%.
Is Phreesia's Days Payable too high?
Phreesia's current Days Payable of 24.60 is near median its 10-year median of 27.01. Over the past 10 years, this metric has ranged from a low of 18.01 to a high of 39.86. The Healthcare Providers & Services industry median Days Payable is 58.21. Phreesia's value of 24.60 is 57.7% below this industry median. Based on the distribution chart, Phreesia ranks #517 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's Days Payable compare to HSTM and WEAV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #517 out of 606 companies for Days Payable. This places Phreesia in the lower half of its industry. The industry median Days Payable is 58.21. Phreesia's value of 24.60 is 57.7% below this benchmark. Historically, Phreesia's own Days Payable has ranged from 18.01 to 39.86 over the past decade. While the company's 10-year median is 27.01 vs. the industry median of 58.21, Phreesia has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current Days Payable of 24.60 is 57.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current Days Payable is 24.60, which is near median its own 10-year median of 27.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (PHR) is currently considered Possible Value Trap. The stock's GF Value™ is $26.97, compared to a current price of $10.07 — trading 62.7% below its estimated fair value. The current Days Payable is 24.60, which is near median its 10-year median of 27.01 and 57.7% below the Healthcare Providers & Services industry median of 58.21. Phreesia's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Phreesia (PHR), the current Days Payable is 24.60 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phreesia (PHR) Overvalued in 2026?
Based on GuruFocus' analysis, Phreesia stock appears to be undervalued.
The current stock price of $10.07 is trading 62.7% below its estimated GF Value™ of $26.97.
GuruFocus considers Phreesia to be Possible Value Trap.
Key valuation signals for PHR:
Days Payable: 24.60 (near median its 10-year median of 27.01)
GF Value™: $26.97 vs. price of $10.07 (62.7% below fair value)
Industry Position: 57.7% below the Healthcare Providers & Services median (#517 of 606)
No single metric tells the full story. See the PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score
Get the complete analysis for PHR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHR has been successfully added to your 
